RENEE FLORESTA-CHAN: Open Payments
NPI 1871119719 · SUN CITY CENTER, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$955 in 53 payments from 18 companies in 2025. Trend: 2023 $1,473 · 2024 $989 · 2025 $955
Food & beverage: $955
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 16 | $198 |
| AstraZeneca Pharmaceuticals LP | 6 | $92 |
| ABBVIE INC. | 3 | $74 |
| Teva Pharmaceuticals USA, Inc. | 3 | $67 |
| Novo Nordisk Inc | 3 | $67 |
| Otsuka America Pharmaceutical, Inc. | 3 | $66 |
| Lilly USA, LLC | 3 | $61 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $57 |
| Sumitomo Pharma America, Inc. | 3 | $47 |
| PFIZER INC. | 2 | $41 |
Products named: OTEZLA, EVENITY, REXULTI, VRAYLAR, AUSTEDO XR, MOUNJARO, AIRSUPRA, Kerendia.
Industry payments across FL — which companies pay providers there.
